Stay updated on Anti-IgE MAb in Allergic Asthma Clinical Trial
Sign up to get notified when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.

Latest updates to the Anti-IgE MAb in Allergic Asthma Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial page now displays the study record for CMAB007 treatment in patients with allergic asthma, including its design, participant criteria, interventions, and outcome measures, instead of an access error.SummaryDifference61%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden response.SummaryDifference0.2%

- Check16 days agoChange DetectedThe record for the CMAB007 allergic asthma clinical trial has been replaced by a 403 Forbidden error. An NIH websites transition notice is also displayed.SummaryDifference21%

- Check23 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating the resource is currently inaccessible. This reflects a permissions/access issue on the site rather than a modification to the study data.SummaryDifference21%

Stay in the know with updates to Anti-IgE MAb in Allergic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.